Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix
Completed · Phase 2
Conditions studied: Cervical Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of topotecan and paclitaxel in treating patients who have recurrent or metastatic cancer of the cervix.
Key facts
- Study ID
- NCT00003065
- Run by
- Herbert Irving Comprehensive Cancer Center
- People needed
- 25
- Starts
- 1997-01-01
- Expected to finish
- 2004-02-01
- Last updated by the study team
- 2014-01-06
Who can join
Age: 18 and older, up to 60. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Herbert Irving Comprehensive Cancer Center at Columbia University — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.